Metabolic syndrome. Metabolic disorder, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Two 0.5 g capsules of synbiotic twice daily for 8 weeks. Intervention 2: Control group: Two 0.5 g placebo capsules (maltodextrin) 2 times daily for 8 weeks.
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
10 Years to 18 Years
Inclusion criteria
Inclusion criteria: Age range 10 to 18 years A parent's willingness to participate in the study and sign the informed consent form Has at least one item of metabolic syndrome Failure to participate in weight loss programs for the past 6 months
Exclusion criteria
Exclusion criteria: Unwillingness to continue attending the study Non-compliance with intervention (less than 90% product use) Major change in energy intake and nutrient intake or consumption of less than 800 kcal and more than 4200 kcal during the study based on the 3-day food registration method Start any weight loss or weight gain diet during the study Individual tobacco use during the study Use of antioxidants, multivitamins or any dietary supplements during intervention Antibiotic use during the study People with mental illnesses, cardiovascular, lung, liver, kidney, cancer, thyroid and eating disorders Type 1 diabetic patients with insulin and hypoglycemic drugs People taking drugs that affect appetite, body weight, blood sugar, lipid profile or anti-inflammatory drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in anthropometric indices and body composition. Timepoint: The beginning and the end of the study. Method of measurement: body composition analysis. | — |
Secondary
| Measure | Time frame |
|---|---|
| "Abdominal Volume Index" and "Conicity Index" and "A Body Shape Index". Timepoint: The beginning and the end of the study. Method of measurement: equation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMotahar Heidari-Beni
Esfahan University of Medical Sciences
Outcome results
None listed